Glenmark gets USFDA final nod for anti-fungal ointment

Glenmark gets USFDA final nod for anti-fungal ointment

PTIUpdated: Thursday, May 30, 2019, 02:40 PM IST
article-image

New Delhi: Glenmark Pharma has received final approval from the health regulator USFDA for anti-fungal ointment nystatin and triamcinolone acetonide. The company also received tentative approval for Olmesartan medoxomil, used for the treatment of high blood pressure. “Glenmark Pharmaceuticals Inc, USA, has been granted final approval by the US Food and Drug Administration (USFDA) for nystatin and triamcinolone acetonide ointment USP, 1,00,000 units/1 mg per gram,” it said in a BSE filing.

Nystatin and triamcinolone acetonide ointment is generic version of Taro while Olmesartan Medoxomil is generic version of Daiichi Sankyo’s Benicar. Glenmark said it will market generic version of Benicar in the strengths of 5mg, 20mg and 40 mg upon receiving final approval.

According to IMS Health sales data for the 12 months to April 2016, Glenmark said Nystatin and triamcinolone acetonide ointment achieved annual sales of around USD 37.5 million. While Benicar achieved annual sales of around USD 1.05 billion for the 12 months period ended April 2016.

The company’s current portfolio consists of 114 products authorised for distribution in the US marketplace and 62 ANDA pending approval with the USFDA. Glenmark Pharmaceuticals shares were trading 4.15 per cent down at Rs 740.95 on BSE during the late morning trade.

RECENT STORIES

SRM Contractors IPO Subscribed 86.57 Times On Last Day Of Bidding

SRM Contractors IPO Subscribed 86.57 Times On Last Day Of Bidding

Tax-Saving Tip From Zerodha CEO Nithin Kamath: 'If You're Married And Hindu..."; Here's How To Save...

Tax-Saving Tip From Zerodha CEO Nithin Kamath: 'If You're Married And Hindu...

Holy Cities Like Ayodhya, Varanasi Attracting Big Retail Brands: Report

Holy Cities Like Ayodhya, Varanasi Attracting Big Retail Brands: Report

A Big Relief For Byjus's: NCLT Rejects Investor Plea To Stay Byju's Rights Issue EGM On March 29...

A Big Relief For Byjus's: NCLT Rejects Investor Plea To Stay Byju's Rights Issue EGM On March 29...

Your Chocolates To Get Costly As Cocoa Price Surges To ₹8,33,892 Per Ton

Your Chocolates To Get Costly As Cocoa Price Surges To ₹8,33,892 Per Ton